Parkinson's Disease

Follow‐up After “Drug Holiday”

Robert G. Feldman, Jeffrey Kaye, Margaret C. Lannon

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Long‐term management of patients with Parkinson's disease includes close monitoring and frequent dose adjustment. In a small selected group of patients, complete withdrawal of l‐dopa (drug holiday) and slow reintroduction of lower doses of this drug assured continued benefit for six to 24 months. We studied 45 drug holidays in 45 patients with idiopathic Parkinson's disease. Average preholiday l‐dopa dose was 2,970 mg/d; at 24 months, it was 263 mg/d. The drug holiday resulted in reduced adverse drug effects (dyskinesias, “on‐off” phenomenon, hallucinations, and confusion), and improved functional ratings at one, six, 12, and 24 months after the drug holiday. 1986 American College of Clinical Pharmacology

Original languageEnglish (US)
Pages (from-to)662-667
Number of pages6
JournalThe Journal of Clinical Pharmacology
Volume26
Issue number8
DOIs
StatePublished - 1986
Externally publishedYes

Fingerprint

Holidays
Parkinson Disease
Pharmaceutical Preparations
Social Adjustment
Confusion
Clinical Pharmacology
Hallucinations
Dyskinesias

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Parkinson's Disease : Follow‐up After “Drug Holiday”. / Feldman, Robert G.; Kaye, Jeffrey; Lannon, Margaret C.

In: The Journal of Clinical Pharmacology, Vol. 26, No. 8, 1986, p. 662-667.

Research output: Contribution to journalArticle

Feldman, Robert G. ; Kaye, Jeffrey ; Lannon, Margaret C. / Parkinson's Disease : Follow‐up After “Drug Holiday”. In: The Journal of Clinical Pharmacology. 1986 ; Vol. 26, No. 8. pp. 662-667.
@article{f8a36210fa9141859d0b6fb7403dffa7,
title = "Parkinson's Disease: Follow‐up After “Drug Holiday”",
abstract = "Long‐term management of patients with Parkinson's disease includes close monitoring and frequent dose adjustment. In a small selected group of patients, complete withdrawal of l‐dopa (drug holiday) and slow reintroduction of lower doses of this drug assured continued benefit for six to 24 months. We studied 45 drug holidays in 45 patients with idiopathic Parkinson's disease. Average preholiday l‐dopa dose was 2,970 mg/d; at 24 months, it was 263 mg/d. The drug holiday resulted in reduced adverse drug effects (dyskinesias, “on‐off” phenomenon, hallucinations, and confusion), and improved functional ratings at one, six, 12, and 24 months after the drug holiday. 1986 American College of Clinical Pharmacology",
author = "Feldman, {Robert G.} and Jeffrey Kaye and Lannon, {Margaret C.}",
year = "1986",
doi = "10.1002/j.1552-4604.1986.tb02969.x",
language = "English (US)",
volume = "26",
pages = "662--667",
journal = "Journal of Clinical Pharmacology",
issn = "0091-2700",
publisher = "SAGE Publications Inc.",
number = "8",

}

TY - JOUR

T1 - Parkinson's Disease

T2 - Follow‐up After “Drug Holiday”

AU - Feldman, Robert G.

AU - Kaye, Jeffrey

AU - Lannon, Margaret C.

PY - 1986

Y1 - 1986

N2 - Long‐term management of patients with Parkinson's disease includes close monitoring and frequent dose adjustment. In a small selected group of patients, complete withdrawal of l‐dopa (drug holiday) and slow reintroduction of lower doses of this drug assured continued benefit for six to 24 months. We studied 45 drug holidays in 45 patients with idiopathic Parkinson's disease. Average preholiday l‐dopa dose was 2,970 mg/d; at 24 months, it was 263 mg/d. The drug holiday resulted in reduced adverse drug effects (dyskinesias, “on‐off” phenomenon, hallucinations, and confusion), and improved functional ratings at one, six, 12, and 24 months after the drug holiday. 1986 American College of Clinical Pharmacology

AB - Long‐term management of patients with Parkinson's disease includes close monitoring and frequent dose adjustment. In a small selected group of patients, complete withdrawal of l‐dopa (drug holiday) and slow reintroduction of lower doses of this drug assured continued benefit for six to 24 months. We studied 45 drug holidays in 45 patients with idiopathic Parkinson's disease. Average preholiday l‐dopa dose was 2,970 mg/d; at 24 months, it was 263 mg/d. The drug holiday resulted in reduced adverse drug effects (dyskinesias, “on‐off” phenomenon, hallucinations, and confusion), and improved functional ratings at one, six, 12, and 24 months after the drug holiday. 1986 American College of Clinical Pharmacology

UR - http://www.scopus.com/inward/record.url?scp=0023028759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023028759&partnerID=8YFLogxK

U2 - 10.1002/j.1552-4604.1986.tb02969.x

DO - 10.1002/j.1552-4604.1986.tb02969.x

M3 - Article

VL - 26

SP - 662

EP - 667

JO - Journal of Clinical Pharmacology

JF - Journal of Clinical Pharmacology

SN - 0091-2700

IS - 8

ER -